NephrosNEPH
Fair Value
US$8
Share price04 Jan
US$4.0849.0% undervalued intrinsic discount
1Y-2.39%
7D-11.78%
PFAS And Water Safety Demand Will Drive Strong Long-Term Upside Potential
AN
Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls
Published
04 Jan 26
Views
10
Not Invested